Key result
Olanzapine treatment in patients with acute schizophrenia reduced heart rate regulation complexity but had no additional impact on QT variability.
Why the study?
Does olanzapine treatment alter QT variability and heart rate complexity in patients with acute schizophrenia?
Observational (n=15)
Does olanzapine treatment alter QT variability and heart rate complexity in patients with acute schizophrenia?
Olanzapine treatment in acute schizophrenia further decreases heart rate complexity without affecting QT variability, suggesting a potential reduction in cardiac vagal function.
May alter cardiac monitoring in schizophrenia; leaves open whether newer antipsychotics worsen autonomic risk.
Previous studies have shown that untreated patients with acute schizophrenia present with reduced heart rate variability and complexity as well as increased QT variability. This autonomic dysregulation might contribute to increased cardiac morbidity and mortality in these patients. However, the additional effects of newer antipsychotics on autonomic dysfunction have not been investigated, applying these new cardiac parameters to gain information about the regulation at sinus node level as well as the susceptibility to arrhythmias. We have investigated 15 patients with acute schizophrenia before and after established olanzapine treatment and compared them with matched controls. New nonlinear parameters (approximate entropy, compression entropy, fractal dimension) of heart rate variability and also the QT-variability index were calculated. In accordance with previous results, we have observed reduced complexity of heart rate regulation in untreated patients. Furthermore, the QT-variability index was significantly increased in unmedicated patients, indicating increased repolarization lability. Reduction of the heart rate regulation complexity after olanzapine treatment was seen, as measured by compression entropy of heart rate. No change in QT variability was observed after treatment. This study shows that unmedicated patients with acute schizophrenia experience autonomic dysfunction. Olanzapine treatment seems to have very little additional impact in regard to the QT variability. However, the decrease in heart rate complexity after olanzapine treatment suggests decreased cardiac vagal function, which may increase the risk for cardiac mortality. Further studies are warranted to gain more insight into cardiac regulation in schizophrenia and the effect of novel antipsychotics.
No takes yet. Share an insight, caveat, or question.
Bär et al. (2008) conducted an observational in Acute schizophrenia (n=15). Olanzapine vs. Unmedicated baseline and matched controls was evaluated on Heart rate variability complexity (approximate entropy, compression entropy, fractal dimension) and QT-variability index. Olanzapine treatment in patients with acute schizophrenia reduced heart rate regulation complexity but had no additional impact on QT variability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: